Is CHRO or FCPT a better dividend investment in 2026?

CHRO currently yields 148.15% with a 5% 5-year dividend growth rate. FCPT yields 6.05% with 5% growth. The better choice depends on your goal: CHRO offers higher current income.

What is the dividend yield difference between CHRO and FCPT?

CHRO has a forward dividend yield of 148.15% ($2.00/share annually). FCPT yields 6.05% ($1.43/share annually). The yield gap is 142.10 percentage points.

Home › Compare › CHRO vs FCPT

CHRO vs FCPT: Dividend Comparison 2026

CHRO yields 148.15% · FCPT yields 6.05%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 CHRO wins by $23.41M in total portfolio value

INVESTMENT

TIME HORIZON10 years

CHRO

● Live price

148.15%

Share price

$1.35

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$23.46M

Annual income

$10,076,148.54

Full CHRO calculator →

FCPT

● Live price

6.05%

Share price

$23.65

Annual div

$1.43

5Y div CAGR

15.8%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$49.1K

Annual income

$5,775.28

Full FCPT calculator →

Portfolio growth — CHRO vs FCPT

📍 CHRO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	CHRO	FCPT
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, CHRO + FCPT cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

CHRO pays

FCPT pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CHRO

Annual income on $10K today (after 15% tax)

$12,592.59/yr

After 10yr DRIP, annual income (after tax)

$8,564,726.26/yr

FCPT

Annual income on $10K today (after 15% tax)

$514.49/yr

After 10yr DRIP, annual income (after tax)

$4,908.99/yr

At 15% tax rate, CHRO beats the other by $8,559,817.27/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CHRO + FCPT for your $10,000?

CHRO: 50%FCPT: 50%

100% FCPT50/50100% CHRO

Portfolio after 10yr

$11.75M

Annual income

$5,040,961.91/yr

Blended yield

42.89%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on FCPT right now

CHRO

Analyst Ratings

Buy

Consensus: Buy

Altman Z

-1.5

Piotroski

2/9

FCPT

Analyst Ratings

Buy

Hold

Consensus: Hold

Price Target

$27.00

+14.2% upside vs current

Range: $25.00 — $29.00

Altman Z

1.4

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CHRO buys

FCPT buys

No recent congressional trades found for CHRO or FCPT in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricCHROFCPT

Forward yield	148.15% ✓	6.05%
Annual dividend / share	$2.00 ✓	$1.43
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	15.8% ✓
Portfolio after 10y	$23.46M	$49.1K ✓
Annual income after 10y	$10,076,148.54 ✓	$5,775.28
Total dividends collected	$21.69M	$24.1K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	REIT
Analyst consensus	Buy	Hold

Year-by-year: CHRO vs FCPT ($10,000, DRIP)

Year	CHRO Portfolio	CHRO Income/yr	FCPT Portfolio	FCPT Income/yr	Gap
1← crossover	$25,515	$14,814.81	$11,401	$700.92	+$14.1K → CHRO
2	$62,628	$35,326.85	$13,064	$864.84	+$49.6K → CHRO
3	$148,051	$81,039.20	$15,051	$1,072.48	+$133.0K → CHRO
4	$337,457	$179,042.34	$17,442	$1,337.22	+$320.0K → CHRO
5	$742,477	$381,398.70	$20,340	$1,677.08	+$722.1K → CHRO
6	$1,578,712	$784,260.93	$23,880	$2,116.57	+$1.55M → CHRO
7	$3,247,684	$1,558,462.68	$28,241	$2,689.36	+$3.22M → CHRO
8	$6,471,310	$2,996,288.20	$33,660	$3,442.07	+$6.44M → CHRO
9	$12,504,097	$5,579,794.89	$40,456	$4,439.95	+$12.46M → CHRO
10	$23,455,532	$10,076,148.54	$49,063	$5,775.28	+$23.41M → CHRO

CHRO vs FCPT: Complete Analysis 2026

CHRO — Stock

Channel Therapeutics Corporation, a clinical-stage biotech company, focuses on the discovery, development, and commercialization of new therapeutics to alleviate pain. The company intends to selectively target the sodium ion-channel known as NaV1.7, as well as other receptors in the NaV family. Its lead compound comprises CC8464, which is in Phase 2a clinical trials for use in the treatment of erythromelalgia, as well as other fields of neuropathic pain. Chromocell Therapeutics Corporation was founded in 2002 and is based in Freehold, New Jersey.

Full CHRO Calculator →

FCPT — REIT

FCPT, headquartered in Mill Valley, CA, is a real estate investment trust primarily engaged in the acquisition and leasing of restaurant properties. The Company seeks to grow its portfolio by acquiring additional real estate to lease, on a net basis, for use in the restaurant and retail industries.

Full FCPT Calculator →

📬

Get this CHRO vs FCPT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CHRO vs SCHD CHRO vs JEPI CHRO vs O CHRO vs KO CHRO vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.